SANGAMO THERAPEUTICS, INC (SGMOQ)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
24
$15.47B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | Feb 12, 2026 | $3.54B |
| Vanguard Capital Management | May 15, 2026 | $3.14B |
| TWO SIGMA INVESTMENTS, LP | May 15, 2026 | $1.55B |
| BALYASNY ASSET MANAGEMENT L.P. | May 15, 2026 | $1.31B |
| GEODE CAPITAL MANAGEMENT, LLC | May 15, 2026 | $1.13B |
SGMOQ's filings are public. The insight is one click away.
Scrutar's AI reads every SGMOQ filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze SGMOQ filingsNo credit cardAI reports included on the free plan
Never miss a SGMOQ filing.
Get an email when SGMOQ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.